Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities.
- DOI
- 10.18433/jpps32260
- Published
- 2021
- Container
- Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.18433/jpps32260,
title = {Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities.},
author = {Roost MS and Potthast H and Walther C and García-Arieta A and Abalos I and Agostinho Freitas Fernandes E and Mendes Lima Santos G and Rodríguez Martínez Z and Tam A and Rodrigues C and Gutierrez Triana DA and Guzmán Aurela E and Rodríguez Rodríguez N and Aeh Park S and Kim J and Kariv R and Divinsky M and Jones B and Kuribayashi R and Myoenzono A and Kasuga M and Van Oudtshoorn J and Chi JF and Hung WY and Hsu LF and Crane C and Jarman T and Braddy A},
year = {2021},
journal = {Journal of pharmacy \& pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques},
doi = {10.18433/jpps32260},
url = {https://doi.org/10.18433/jpps32260}
}RIS
TY - JOUR TI - Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities. AU - Roost MS AU - Potthast H AU - Walther C AU - García-Arieta A AU - Abalos I AU - Agostinho Freitas Fernandes E AU - Mendes Lima Santos G AU - Rodríguez Martínez Z AU - Tam A AU - Rodrigues C AU - Gutierrez Triana DA AU - Guzmán Aurela E AU - Rodríguez Rodríguez N AU - Aeh Park S AU - Kim J AU - Kariv R AU - Divinsky M AU - Jones B AU - Kuribayashi R AU - Myoenzono A AU - Kasuga M AU - Van Oudtshoorn J AU - Chi JF AU - Hung WY AU - Hsu LF AU - Crane C AU - Jarman T AU - Braddy A PY - 2021 JO - Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques DO - 10.18433/jpps32260 UR - https://doi.org/10.18433/jpps32260 ER -
APA
MS, R., H, P., C, W., A, G., I, A., E, A. F. F., G, M. L. S., Z, R. M., A, T., C, R., DA, G. T., E, G. A., N, R. R., S, A. P., J, K., R, K., M, D., B, J., R, K., A, M., M, K., J, V. O., JF, C., WY, H., LF, H., C, C., T, J., & A, B. (2021). Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities.. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. https://doi.org/10.18433/jpps32260
Source records
- pubmed · retrieved 2026-09-25T05:43:29.931Z